Anticancer drug development guide (41 Ergebnisse)

Hardcover. Zustand: Very Good. No Jacket. Former library book; May have limited writing in cover pages. Pages are unmarked. ~ ThriftBooks: Read More, Spend Less.

Hardcover. Zustand: Very Good. No Dust Jacket. Second Edition; First Printing. A tight and clean copy. Light rubbing and toning overall. Interior pages clean and unmarked. Photos upon request. International shipping billed at cost.; Cancer Drug Discovery And Development; Large 8vo 9" - 10" tall; 465 pages.…

hardcover. Zustand: Good. Connecting readers with great books since 1972! Used textbooks may not include companion materials such as access codes, etc. May have some wear or writing/highlighting. We ship orders daily and Customer Service is our top priority.

hardcover. Zustand: Sehr gut. 465 Seiten; 9781588292285.2 Gewicht in Gramm: 2.

Zustand: New. In English.

Hardcover. Zustand: new. New Copy. Customer Service Guaranteed.

hardcover. Zustand: New. In shrink wrap. Looks like an interesting title.

Zustand: New. Satisfaction Guaranteed or your money back.

Zustand: New.

Taschenbuch. Zustand: Neu. Neuware.

Zustand: New. In English.

Zustand: New. Editor(s): Teicher, Beverly A. Series: Cancer Drug Discovery & Development. Num Pages: black & white illustrations, bibliography. BIC Classification: MJCL; MMG. Category: (G) General (US: Trade). Dimension: 254 x 178 x 18. Weight in Grams: 572. . 2013. Paperback / so. . . . .

Taschenbuch. Zustand: Neu. Anticancer Drug Development Guide | Preclinical Screening, Clinical Trials, and Approval | Beverly A. Teicher | Taschenbuch | Cancer Drug Discovery and Development | xii | Englisch | 2013 | Humana | EAN 9781461581543 | Verantwortliche Person für die EU: Humana Press in Springer Science + Business Media, Heidelberger Platz 3, 14197 Berlin, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.…

Zustand: New. Editor(s): Teicher, Beverly A. Series: Cancer Drug Discovery & Development. Num Pages: black & white illustrations, bibliography. BIC Classification: MJCL; MMG. Category: (G) General (US: Trade). Dimension: 254 x 178 x 18. Weight in Grams: 572. . 2013. Paperback / so. . . . . Books ship from the US and Ireland.…

Zustand: New. In English.

Zustand: New. Editor(s): Teicher, Beverly A.; Andrews, Paul A. Series: Cancer Drug Discovery and Development. Num Pages: 451 pages, 161 black & white illustrations, biography. BIC Classification: MJCL; MMG. Category: (P) Professional & Vocational. Dimension: 254 x 178 x 24. Weight in Grams: 883. . 2012. Softcover reprint of the original 1st ed. 2004. Paperback. . . . . …

Paperback. Zustand: Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.

Taschenbuch. Zustand: Neu. Anticancer Drug Development Guide | Preclinical Screening, Clinical Trials, and Approval | Beverly A. Teicher (u. a.) | Taschenbuch | Cancer Drug Discovery and Development | xiv | Englisch | 2012 | Humana | EAN 9781468498417 | Verantwortliche Person für die EU: Humana Press in Springer Science + Business Media, Heidelberger Platz 3, 14197 Berlin, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.…

Zustand: As New. Unread book in perfect condition.

Zustand: New. pp. 468.

Paperback. Zustand: Brand New. reprint edition. 465 pages. 9.75x7.00x1.25 inches. In Stock.

Zustand: New. Editor(s): Teicher, Beverly A.; Andrews, Paul A. Series: Cancer Drug Discovery and Development. Num Pages: 451 pages, 161 black & white illustrations, biography. BIC Classification: MJCL; MMG. Category: (P) Professional & Vocational. Dimension: 254 x 178 x 24. Weight in Grams: 883. . 2012. Softcover reprint of the original 1st ed. 2004. Paperback. . . . . Books ship from the US and Ireland. …

Zustand: New. In English.

Zustand: New. Provides a step-by-step guide to anticancer drug development from initial design through FDA approval. The authors have included material on the use of high throughput screening in industry, and on specialized in vitro/in vivo procedures employed by the National Cancer Institute (NCI) in preclinical drug evaluations. Editor(s): Teicher, Beverly A.; Andrews, Paul. Series: Cancer Drug Discovery and Development. Num Pages: 451 pages, 161 black & white illustrations, biography. BIC Classification: MJCL; MMG. Category: (P) Professional & Vocational; (UP) Postgraduate, Research & Scholarly; (UU) Undergraduate. Dimension: 254 x 178 x 25. Weight in Grams: 2260. . 2004. 2 Rev ed. Hardback. . . . . …

Zustand: New. Provides a step-by-step guide to anticancer drug development from initial design through FDA approval. The authors have included material on the use of high throughput screening in industry, and on specialized in vitro/in vivo procedures employed by the National Cancer Institute (NCI) in preclinical drug evaluations. Editor(s): Teicher, Beverly A.; Andrews, Paul. Series: Cancer Drug Discovery and Development. Num Pages: 451 pages, 161 black & white illustrations, biography. BIC Classification: MJCL; MMG. Category: (P) Professional & Vocational; (UP) Postgraduate, Research & Scholarly; (UU) Undergraduate. Dimension: 254 x 178 x 25. Weight in Grams: 2260. . 2004. 2 Rev ed. Hardback. . . . . Books ship from the US and Ireland. …

PAP. Zustand: New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.

PAP. Zustand: New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.

Zustand: New. Print on Demand.

Zustand: new. Questo è un articolo print on demand.

Taschenbuch. Zustand: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Experienced cancer researchers from pharmaceutical companies, government laboratories, and academia comprehensively review and describe the arduous process of cancer drug discovery and approval. They focus on using preclinical in vivo and in vitro methods to identify molecules of interest, detailing the targets and criteria for success in each type of testing and defining the value of the information obtained from the various tests. They also define each stage of clinical testing, explain the criteria for success, and outline the requirements for FDA approval. A companion volume by the same editor (Cancer Therapeutics: Experimental and Clinical Agents) reviews existing anticancer drugs and potential anticancer therapies. These two volumes in the Cancer Drug Discovery and Development series reveal how and why molecules become anticancer drugs and thus offer a blueprint for the present and the future of the field. 328 pp. Englisch.…